Mcgill University Health Centre/research Institute Of The Mcgill University Health Centre
Clinical trials sponsored by Mcgill University Health Centre/research Institute Of The Mcgill University Health Centre, explained in plain language.
-
Stem cell COVID trial halted early – what happened?
Disease control TerminatedThis study tested whether stem cells from donated umbilical cords could help hospitalized adults with severe COVID-19 avoid needing a breathing tube or dying. Nineteen participants received either the stem cells or a placebo, plus standard care. The trial was stopped early, so re…
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 26, 2026 05:30 UTC
-
Lung cancer immunotherapy trial halted after just 6 patients
Disease control TerminatedThis study tested whether giving the immunotherapy drug pembrolizumab (Keytruda) before surgery, alone or with chemotherapy, helps shrink early-stage non-small cell lung cancer. Only 6 people enrolled before the trial was stopped early. The main goal was to see if the treatment c…
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 26, 2026 05:24 UTC
-
Lung drug safety study in muscle disease patients ends early
Disease control TerminatedThis study looked at whether the drug nintedanib is safe and tolerable for people with a type of lung disease caused by myositis (muscle inflammation). Researchers planned to enroll adults with scarring in the lungs, but the study was stopped early after only 11 participants. The…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
COPD breathlessness study halted: did fentanyl offer relief?
Symptom relief TerminatedThis study looked at whether a fentanyl tablet placed under the tongue could reduce shortness of breath and improve exercise ability in people with severe COPD. The trial included 40 adults aged 40 and older with advanced COPD who still felt breathless despite standard treatments…
Phase: PHASE2, PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Symptom relief
Last updated May 18, 2026 12:10 UTC